Prevalence of Helicobacter pylori infection in patients with upper gastrointestinal disorders using different methods in Khuzestan, Southwest Iran
- PMID: 40788504
- DOI: 10.1007/s11033-025-10905-5
Prevalence of Helicobacter pylori infection in patients with upper gastrointestinal disorders using different methods in Khuzestan, Southwest Iran
Abstract
Background: Helicobacter pylori (H. pylori) has been strongly associated with gastroduodenal pathologies, including gastritis, peptic ulcers, and gastric cancer. This study aimed to determine the prevalence of H. pylori infection in Khuzestan Province, Southwest Iran, identify demographic and clinical predictors, and evaluate the effect of proton pump inhibitors (PPIs), antibiotics, and bismuth on the accuracy of diagnostic tests.
Methods and results: In this cross-sectional study, 550 patients (aged 12-94 years) with gastrointestinal disorders underwent upper endoscopy. Demographic data, medication history, and endoscopic findings were recorded. Four antral biopsies per patient were collected and analyzed for H. pylori infection using the rapid urease test (RUT), histology, culture, and polymerase chain reaction (PCR) for confirmatory testing. Univariate logistic regression assessed the effects of medications on diagnostic results. The overall prevalence of H. pylori infection was 51.8% (285/550). Histology demonstrated higher sensitivity than RUT and culture. After adjustment for age and sex, the 31-40-year and 41-50-year age groups exhibited significantly higher odds of infection compared to the ≤ 30-year reference group. Multivariate analysis identified melena, duodenal ulcer, antral nodularity, and hiatal hernia as independent predictors of infection. Recent use of PPIs, antibiotics, or bismuth reduced the sensitivity of both RUT and histology; however, histology retained greater diagnostic reliability.
Conclusions: The high prevalence of H. pylori infection in Khuzestan Province emphasizes the development of eradication programs. Melena, duodenal ulcer, and antral nodularity are key clinical predictors. The novel association between H. pylori infection and hiatal hernia requires further studies to understand the underlying mechanisms. When discontinuing PPIs, antibiotics, or bismuth before testing is impractical in order to minimize false negatives, combining PCR with histology can improve diagnostic accuracy.
Keywords: Helicobacter pylori; Bismuth; Gastrointestinal disorders; Histology; Proton pump inhibitor; Rapid urease test.
© 2025. The Author(s), under exclusive licence to Springer Nature B.V.
Conflict of interest statement
Declarations. Ethics approval and consent to participate: This study was approved by the Ethics Review Committee of Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran following the Declaration of Helsinki (ethics code: IR.AJUMS.MEDICINE.REC.1402.048). Informed consent was obtained from all participants. Consent for publication: Not applicable. Competing interests: The authors declare no competing interests.
Similar articles
-
Optimum duration of regimens for Helicobacter pylori eradication.Cochrane Database Syst Rev. 2013 Dec 11;2013(12):CD008337. doi: 10.1002/14651858.CD008337.pub2. Cochrane Database Syst Rev. 2013. PMID: 24338763 Free PMC article.
-
Non-invasive diagnostic tests for Helicobacter pylori infection.Cochrane Database Syst Rev. 2018 Mar 15;3(3):CD012080. doi: 10.1002/14651858.CD012080.pub2. Cochrane Database Syst Rev. 2018. PMID: 29543326 Free PMC article.
-
Gastric cancer risk after Helicobacter pylori eradication in gastritis and peptic ulcer: a retrospective cohort study in Japan.BMC Gastroenterol. 2025 Jul 1;25(1):463. doi: 10.1186/s12876-025-04034-3. BMC Gastroenterol. 2025. PMID: 40596880 Free PMC article.
-
Helicobacter pylori and gastric or duodenal ulcer.Prescrire Int. 2016 Jan;25(167):18-23. Prescrire Int. 2016. PMID: 26942258
-
Eradication therapy for peptic ulcer disease in Helicobacter pylori-positive people.Cochrane Database Syst Rev. 2016 Apr 19;4(4):CD003840. doi: 10.1002/14651858.CD003840.pub5. Cochrane Database Syst Rev. 2016. PMID: 27092708 Free PMC article.
References
-
- Ali A, AlHussaini KI (2024) Helicobacter pylori: a contemporary perspective on pathogenesis, diagnosis and treatment strategies. Microorganisms 12(1):222. https://doi.org/10.3390/microorganisms12010222 - DOI - PubMed - PMC
-
- Katelaris P, Hunt R, Bazzoli F, Cohen H, Fock KM, Gemilyan M, Malfertheiner P, Mégraud F, Piscoya A, Quach D, Vakil N, Vaz Coelho LG, LeMair A, Melberg J (2023) Helicobacter pylori world gastroenterology organization global guideline. J Clin Gastroenterol 57(2):111–126. https://doi.org/10.1097/mcg.0000000000001719 - DOI - PubMed
-
- Reyes VE (2023) Helicobacter pylori and its role in gastric cancer. Microorganisms 17(5):1312. https://doi.org/10.3390/microorganisms11051312 - DOI
-
- Wang Y, Du J, Zhang D, Jin C, Chen J, Wang Z, Mei T, Fu K, Qian Q, Pang T (2023) Primary antibiotic resistance in Helicobacter pylori in china: a systematic review and meta-analysis. J Glob Antimicrob Resist 34:30–38. https://doi.org/10.1016/j.jgar.2023.05.014 - DOI - PubMed
-
- Duan M, Li Y, Liu J, Zhang W, Dong Y, Han Z, Wan M, Lin M, Lin B, Kong Q, Ding Y, Yang X, Zuo X, Li Y (2023) Transmission routes and patterns of Helicobacter pylori. Helicobacter 28(1):e12945. https://doi.org/10.1111/hel.12945 - DOI - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical